Actively Recruiting
Community and School-Based Screening for Rheumatic Heart Disease in Sindh with Secondary Prevention Treatment and Follow-Up
Led by National Institute of Cardiovascular Diseases, Pakistan · Updated on 2023-08-15
5000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating Rheumatic Heart Disease RHD, a significant health issue that can be detected early using a simple and sensitive test called point of care ultrasound. The study aims to understand how often RHD occurs and how common it is in community and school settings. Early diagnosis and treatment through secondary prevention with antibiotic prophylaxis may slow the disease progression and improve outcomes in a cost-effective way. The study involves basic clinical screening including medical history and physical examination followed by point of care ultrasound to examine the Mitral, Aortic, and Tricuspid valves for signs of valve regurgitation or stenosis. Patients diagnosed with RHD will receive treatment and referrals based on their disease stage. Antibiotic delivery may be shifted to community health workers using clinical algorithms, diagnostic tools, and supervision. Repeat imaging will be done at 2 and 5 years to monitor the progression of valve disease. Participants will undergo initial clinical and ultrasound assessments to confirm RHD status. Follow-up imaging occurs at two and five years to observe disease outcomes. Researchers will measure the presence of Rheumatic Heart Disease at the time of the screening echocardiogram. The study provides ongoing monitoring to evaluate delayed valve disease progression over time. Overall participation duration may extend up to 5 years, with periodic evaluations to assess heart valve status and treatment effects.
CONDITIONS
Brief Title
Screening and Secondary Prevention Rheumatic Heart Disease Study
Research Team
S
Sabha Bhatti, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here